Healthscope Ltd (HSO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Healthscope Ltd (HSO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11503
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Healthscope Ltd (Healthscope) is an integrated healthcare provider that provides healthcare services through the ownership and management of hospitals and pathology laboratories. The company operates through private hospitals in Australia and pathology laboratories in New Zealand. It provides a range of specialist orientated, multi-disciplinary healthcare services including acute, medical, maternity, mental health and rehabilitation services. Healthscope also provides pathology diagnostic services in New Zealand. The company also provides veterinary pathology services in New Zealand through Gribbles Veterinary. The company operates in Australia, New Zealand and South East Asia. Healthscope is headquartered in Melbourne, Victoria, Australia.

Healthscope Ltd (HSO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Healthscope Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Healthscope Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Healthscope Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Healthscope Prices IPO 10
Asset Transactions 12
Sonic Healthcare Receives ACCC Approval To Acquire Pathology Business In Australian Capital Territory And Southern Tablelands From Healthscope 12
Acquisition 14
HCA Holdings Rumored To Bid For Healthscope For US$4.5 Billion 14
Healthscope Ltd – Key Competitors 16
Healthscope Ltd – Key Employees 17
Healthscope Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Financial Announcements 20
Feb 15, 2018: Healthscope 2018 First Half Results 20
Aug 23, 2017: Healthscope 2017 Full Year Results 23
Corporate Communications 26
Jan 08, 2018: Healthscope Appoints Michael Stanford To Board 26
Apr 03, 2017: Gordon Ballantyne to succeed Robert Cooke as Healthscope Managing Director and CEO 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Healthscope Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Healthscope Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Healthscope Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Healthscope Prices IPO 10
Sonic Healthcare Receives ACCC Approval To Acquire Pathology Business In Australian Capital Territory And Southern Tablelands From Healthscope 12
HCA Holdings Rumored To Bid For Healthscope For US$4.5 Billion 14
Healthscope Ltd, Key Competitors 16
Healthscope Ltd, Key Employees 17
Healthscope Ltd, Subsidiaries 18

List of Figures
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Healthscope Ltd, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Healthscope Ltd (HSO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Berkeley Energia Ltd:企業の戦略・SWOT・財務分析
    Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report Summary Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Busan Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PaxVax Inc (PaxVax) is a vaccine company that develops and commercializes specialty vaccines against infectious diseases. The company develops scalable, and oral vaccines. Its activities include early-stage preclinical research and development, clinical study support, drug product manufactur …
  • Litha Healthcare Group Ltd-医療機器分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Amazon.com, Inc.:企業の戦略・SWOT・財務情報
    Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mace Group Ltd:企業の戦略・SWOT・財務情報
    Mace Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Mace Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cornell University-医療機器分野:企業M&A・提携分析
    Summary Cornell University (CU) is an educational institute that offers graduate and undergraduate education and research services. The institute offers education in biological and environmental engineering, communication, crop and soil sciences, development sociology, biological statistics and comp …
  • Neurim Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Neurim Pharmaceuticals Ltd (Neurim) is a drug discovery company that develops drugs for central nervous system diseases.The company's product line includes circadin that is used in insomnia treatment. Neurim offers paediatric prolonged-release melatonin, piromelatine, NEU-P12 and NEU-240. Th …
  • Bilfinger SE (GBF):石油・ガス:M&Aディール及び事業提携情報
    Summary Bilfinger SE (Bilfinger) is a provider of industrial engineering services. It offers a wide range of services from consulting, construction, manufacturing, plant expansion to maintenance and project management services across diverse end markets. The company’s major service offerings include …
  • Mega Financial Holding Co., Ltd.:戦略・SWOT・企業財務分析
    Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Medigen Biotechnology Corp (3176):企業の財務・戦略的SWOT分析
    Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cyclopharm Ltd (CYC):医療機器:M&Aディール及び事業提携情報
    Summary Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine business. The company’s products include Technegas, a lung imaging device used to diagnose the presence of blood clots in the lungs; and posi …
  • Nohla Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nohla Therapeutics Inc (Nohla Therapeutics) focuses on the development of universal, off-the-shelf cell therapies for the treatment of hematologic malignancies and other critical diseases. The company develops clinical, preclinical and discovery programs based on its proprietary notch ligand …
  • Ibersol S.G.P.S., S.A.
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Energy Absolute Public Co Ltd (EA):電力:M&Aディール及び事業提携情報
    Summary Energy Absolute Public Co Ltd (Energy Absolute), formerly Suntech Palm Oil Ltd, is a renewable energy service provider that offers opportunities for networking, education and business creation. The company provides products such as biodiesel and glycerin. It offers services such as dry washi …
  • Focus Media Holding Ltd:企業のM&A・事業提携・投資動向
    Focus Media Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Focus Media Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Hansgrohe SE:企業の戦略・SWOT・財務情報
    Hansgrohe SE - Strategy, SWOT and Corporate Finance Report Summary Hansgrohe SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Lincoln Electric System:企業の戦略的SWOT分析
    Lincoln Electric System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Goodfellow Inc (GDL):企業の財務・戦略的SWOT分析
    Goodfellow Inc (GDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆